As of November 6, 2026, Vivos Therapeutics, Inc. is a publicly traded company (Nasdaq: VVOS). The largest holder reporting an active stake on Schedule 13D is V-Co Investors 4 LLC, at 19.9%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include Dawei Luo (8.52%) (Schedule 13D, July 15, 2026).
Is this your company?
About to sign with, pay or invest in Vivos Therapeutics, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Vivos Therapeutics, Inc. a real, registered company?
- Vivos Therapeutics, Inc. files with the SEC under CIK 1716166 (its SEC filings).
- Its shares are listed under the ticker VVOS on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Littleton, Colorado, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Vivos Therapeutics, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Bradford Amman, Chief Financial Officer (Form 8-K filed 2026-08-03). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Streeterville Capital LLC (filed 2026-08-11).
Who are Vivos Therapeutics, Inc.'s owners and officers?
Vivos Therapeutics, Inc.: incorporated in Delaware; business address in Littleton, Colorado; industry Surgical & Medical Instruments & Apparatus (Form 8-K, 2026-10-19).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-09-03 | Streeterville Capital LLC | 0.6% |
| Schedule 13G/A, 2026-08-14 | Armistice Capital, LLC | 4.99% |
| Schedule 13G, 2026-08-11 | Streeterville Capital LLC | 9.3% |
| Schedule 13D, 2026-07-15 | V-Co Investors 4 LLC | 19.9% |
| Schedule 13G, 2026-05-15 | Armistice Capital, LLC | 8.27% |
| Schedule 13D, 2026-04-02 | V-Co Investors 3 LLC | 19.9% |
| Schedule 13G, 2025-07-14 | Dawei Luo | 8.52% |
Questions about who owns Vivos Therapeutics, Inc.
Who owns Vivos Therapeutics, Inc.?
On this page, 3 holders' latest ownership filings report 5% or more of Vivos Therapeutics, Inc.: V-Co Investors 4 LLC (19.9%, Schedule 13D, filed 2026-07-15), V-Co Investors 3 LLC (19.9%, Schedule 13D, filed 2026-04-02) and Dawei Luo (8.52%, Schedule 13G, filed 2025-07-14).
Who are the largest shareholders of Vivos Therapeutics, Inc.?
By the share each holder's latest filing reports, the largest holders of Vivos Therapeutics, Inc. on this page are V-Co Investors 4 LLC (19.9%), V-Co Investors 3 LLC (19.9%) and Dawei Luo (8.52%).
When did V-Co Investors 4 LLC buy into Vivos Therapeutics, Inc.?
The filings give report dates, not purchase dates. The earliest filing from V-Co Investors 4 LLC on this page is the Schedule 13D, filed 2026-07-15, reporting 19.9%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 7 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Vivos Therapeutics, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Vivos Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Vivos Therapeutics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
17 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-08-03 | Bradford Amman | Chief Financial Officer | departed | |
| Form 8-K, 2026-08-03 | Roman Franklin | Chief Financial Officer | appointed | 2026-07-31 |
Which insiders own Vivos Therapeutics, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a 10% owner: 1,353,625 shares (6.7% of shares outstanding), held indirectly through By V-CO Investors 3 LLC, on a joint filing (Form 4, 2026-04-02).
- V-Co Investors 3 LLC, a 10% owner: 1,353,625 shares (6.7% of shares outstanding) (Form 3, 2026-04-10).
- , the principal accounting officer: 250,080 shares (1.2% of shares outstanding) (Form 4, 2026-08-26).
- , the chief executive and a director: 73,061 shares (0.36% of shares outstanding), 3,461 held directly and 69,600 indirectly (Form 4, 2026-09-18).
- , a director: 3,997 shares (0.02% of shares outstanding), held indirectly (the form names the holder only in its footnotes) (Form 4, 2026-09-18).
Shares outstanding: 20,118,023 as of 2026-08-13, from the company's latest SEC cover page.
How much has Vivos Therapeutics, Inc. raised?
Latest IPO step: Vivos Therapeutics, Inc. amended its IPO registration (S-1/A, 2025-01-29).
IPO filings: S-1/A, 2025-01-29, S-1, 2025-01-22; ticker VVOS on Nasdaq.
Acquisitions reported on Form 8-K, Item 2.01: acquired Series C Preferred (2026-10-19).
Keep reading
More on Vivos Therapeutics, Inc. and the records around it.
Vivos Therapeutics, Inc. elsewhere on the record
- Acquisition Oct 2026
- 5%+ stake filings Sep 2026
- Leadership changes Aug 2026
Companies that share a holder
- Streeterville Capital LLC also filed stake reports on 29 other companies: Professional Diversity Network, Inc. (Oct 2026), Solowin Holdings, Ltd. (Oct 2026), Empery Digital Inc. (Aug 2026)
- Armistice Capital, LLC also filed stake reports on 120 other companies: Autolus Therapeutics plc (Aug 2026), Bicycle Therapeutics plc (Aug 2026), BioXcel Therapeutics, Inc. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/vivos-therapeutics